IL6 and geroderma osteodysplastica: Given that IL-6 signaling pathway constitutes one of the main pathways involved in the GO pathogenesis, this review aims to summarize the up-to-date knowledge regarding the use of TCZ for active moderate-to-severe GO cases which have not responded to corticosteroids and to determine when the appropriate time is for effective therapeutic intervention with TCZ (4–6).